15 November 2023

Herbert Smith Freehills appoints new Pharma Co-Head

Herbert Smith Freehills has appointed Chris Parker KC as Co-Head of the firm's Pharmaceuticals group.Chris is a partner specialising in international ...

1 November 2023

Herbert Smith Freehills advises Zydus Lifesciences Limited on acquisition of the UK based LiqMeds Group

Leading international law firm Herbert Smith Freehills has advised Zydus Pharmaceuticals UK Limited, a 100% subsidiary of Indian multinational ...

28 September 2023

Herbert Smith Freehills advises CICC as sole sponsor on Neusoft Xikang's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为东软熙康香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation (CICC) as the sole sponsor of Neusoft Xikang ...

12 June 2023

Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人和整体协调人律师为科笛集团香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s ...

5 May 2023

Kewei promotes capital markets international partner in China joint operation with Herbert Smith Freehills 科伟史密夫斐尔联营办公室晋升资本市场业务资深国际顾问

Kewei Law Firm has promoted Agatha Shen as an international partner in Shanghai, further strengthening China capital markets expertise in the firm's ...

27 April 2023

Herbert Smith Freehills advises joint sponsors on MedSci Healthcare's Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为梅斯健康香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie ...

15 December 2022

Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised CICC and CSCI as joint sponsors of 3D Medicines Inc. (01244.HK)’s mainboard listing ...

18 November 2022

Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询

Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a ...

8 November 2022

Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor of LEPU ScienTech ...

10 October 2022

Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation and Citigroup as joint sponsors of Jenscare ...

1 September 2022

Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and ...

19 August 2022

Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务

Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity ...